Corpus Intelligence IC Memo — AVERA ST. BENEDICT HEALTH CENTER 2026-04-26 05:28 UTC
IC Memo — AVERA ST. BENEDICT HEALTH CENTER
Investment Committee Memorandum | SD | 25 beds | Grade C | EBITDA uplift $2.0M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

AVERA ST. BENEDICT HEALTH CENTER

CCN 431330 | HUTCHINSON, SD | 25 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

AVERA ST. BENEDICT HEALTH CENTER is a 25-bed rural/critical access in HUTCHINSON, SD with $27.3M in net patient revenue and a 15.0% operating margin. The hospital serves a payer mix of 70.0% Medicare, 1.7% Medicaid, and 28.3% commercial.

Thesis: Turnaround. Our ML models identify $2.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 15.0% to 22.3% (+736bps).

Net Revenue HCRIS$27.3M
Current EBITDA COMPUTED$4.1M
Operating Margin COMPUTED15.0%
Occupancy HCRIS27.5%
Revenue / Bed COMPUTED$1.1M
Net-to-Gross HCRIS53.3%
Distress Probability ML57.0%

2. Market Context & Competitive Position

63
SD Hospitals
-3.2%
State Median Margin
42
Comparable Hospitals

SD has 63 Medicare-certified hospitals with a median operating margin of -3.2%. The target's margin of 15.0% places it above the state median. Among 42 size-comparable peers (12-50 beds), the median margin is -2.5%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 42 hospitals in the comp set.

HospitalStateBedsRevenueMargin
AVERA ST. BENEDICT HEALTH CENT (Target)SD25$27.3M15.0%
AVERA ST. LUKESSD50$210.6M-7.3%
SIOUX FALLS SPECIALTY HOSPITALSD33$138.8M31.7%
AVERA QUEEN OF PEACESD50$129.2M-8.7%
AVERA SACRED HEART HOSPITALSD42$123.1M-1.9%
AVERA QUEEN OF PEACESD25$122.9M-5.8%
MONUMENT HEALTH SPEARFISH HOSPSD27$116.6M1.9%
SIOUXLAND SURGERY CENTERSD38$105.7M40.1%
AVERA ST MARYSSD50$105.0M-10.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.0M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$573K+210bp18mo
Cost to Collect4.5%2.5%$546K+200bp12mo
Denial Rate Reduction12.0%6.5%$540K+198bp12mo
A/R Days Reduction5200.0%3800.0%$332K+122bp9mo
Clean Claim Rate88.0%96.0%$17K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$573K
Cost to Collect
$546K
Denial Rate Reduction
$540K
A/R Days Reduction
$332K
Clean Claim Rate
$17K
Total EBITDA Uplift$2.0M
Current EBITDA$4.1M
+ RCM Uplift+$2.0M
Pro Forma EBITDA$6.1M
Current Margin15.0%
Pro Forma Margin22.3%
WC Released (1x)$1.0M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$6.3M$47.0M7.49x49.6%
Base (11x exit)10.0x11.0x$6.3M$53.7M8.56x53.6%
Bull Case9.0x11.0x$5.7M$62.4M11.04x61.7%
Bull (12x exit)9.0x12.0x$5.7M$69.8M12.34x65.3%
Bear Case11.0x10.0x$6.9M$34.9M5.06x38.3%
Bear (11x exit)11.0x11.0x$6.9M$40.7M5.89x42.5%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 70.0% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
MediumLow occupancyAt 27.5%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 57.0% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 42 hospitals with 12-50 beds
  • Same-state prioritization (n=43)
  • Comp margins: P25=-9.2% / P50=-2.5% / P75=8.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.